However we observed a higher proportion of serous carcinomas (66%, Table 1C) with high K5 immunostaining which is comparable to a recent study reporting 50% K5 positivity in serous ovarian carcinomas [50]. The gene discussed is KRT5; the disease is ovarian serous carcinoma.